Parameters |
Value |
Distribution |
LL |
UL |
Source |
Clinical Input Parameters- Sourced from UK Based Study |
Probability of chest infection episodes per month-Pre VestTM system |
28.3% |
Beta |
21.26% |
35.43% |
UK-based study |
Probability of admissions per patient per month -Pre VestTM system |
8.9% |
Beta |
6.71% |
11.19% |
UK-based study |
Probability of rate of antibiotic treatments per month-Pre VestTM system |
18.0% |
Beta |
13.47% |
22.45% |
UK-based study |
Average length of stay in hospital in each admission |
11.78 |
Gamma |
5.89 |
17.67 |
UK-based study |
Probability of chest infection episodes per month-Post VestTM system |
3.1% |
Beta |
2.31% |
3.85% |
UK-based study |
Probability of admissions per patient per month ->Post VestTM system |
4.1% |
Beta |
3.06% |
5.10% |
UK-based study |
Probability of rate of antibiotic treatments per month-Post VestTMsystem |
16.2% |
Beta |
12.17% |
20.29% |
UK-based study |
Average length of stay in hospital in each admission |
3.75 |
Gamma |
1.88 |
5.63 |
UK-based study |
Clinical Input Parameters- Sourced from Yuan et al. 2010 |
% of participants requiring hospitalization/IV antibiotics at 5 months - MCWP |
6.4% |
Beta |
4.84% |
8.06% |
Yuan et al. 2010 [4] |
% of participants requiring PO antibiotics at 5 months - MCWP |
11.0% |
Beta |
8.26% |
13.76% |
Yuan et al. 2010 [4] |
% of participants requiring hospitalization/IV antibiotics at 5 months - HFCWO (The VestTMsystem) |
0.0% |
Beta |
0.00% |
0.00% |
Yuan et al. 2010 [4] |
% of participants requiring PO antibiotics at 5 months - HFCWO (The VestTM system) |
5.3% |
Beta |
3.98% |
6.64% |
Yuan et al. 2010 [4] |
Clinical Input Parameters- Sourced from Lechtzin et al. 2016 |
Risk reduction in inpatient admissions |
20.2% |
Fixed |
NA |
NA |
Lechtzin et al. 2016 [11] |
Risk reduction in inpatient bed days |
44.8% |
Fixed |
NA |
NA |
Lechtzin et al. 2016 [11] |
Risk reduction inphysician office visits |
8.2% |
Fixed |
NA |
NA |
Lechtzin et al. 2016 [11] |